×
Breaking News
FDA APPROVES AQVESME™ (mitapivat) | First Oral Therapy for Anaemia Across All Forms of Thalassaemia
PUTTING PATIENTS FIRST IN CLINICAL RESEARCH | New EU Recommendations to Reduce Trials Bureaucracy
EU AGREES LANDMARK REFORM OF PHARMACEUTICAL LEGISLATION | What It Means for Patients and Public Health
1st TIF NURSING WORKSHOP ON HAEMOGLOBINOPATHIES | 29-30 November 2025
1st TIF NURSING WORKSHOP ON HAEMOGLOBINOPATHIES | 29-30 November 2025
TOPICS IN FOCUS SERIES | Guidelines for the Management of Thalassaemia Syndromes
ANNUAL REPORT 2024 | A Year of Resilience and Progress
SICKLE CELL DISEASE | Inflammation during Menstrual Cycle May Trigger Pain Crises
SEVERE APLASTIC ANAEMIA | Stem Cell Transplant Opens New Possibilities
BOOSTING DONOR HEALTH | How Iron Speeds Post-Donation Recovery
English
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Other Anaemias
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
Webinars
/
SCD e-Course Webinars
SCD e-Course Webinars
January 27, 2022
SCD e-Course for Healthcare Professionals
Read More »
January 27, 2022
1st Global Annual IASG Meeting
Read More »
Back to top button
Close
Search for
